Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New registry aims to open MRI access for thousands with heart devices

NCT ID NCT07189728

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 39 times

Summary

This registry will enroll 1,500 adults with pacemakers or defibrillators to see if it is safe to have an MRI in situations not yet well studied, such as using a 3-tesla scanner or having abandoned leads. Participants will undergo a clinically needed MRI, and researchers will monitor for heart rhythm changes or heart muscle damage. The goal is to gather evidence that could update medical guidelines and allow more patients with these devices to get MRIs when needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MRI scan (diagnostic test)

What this could lead to

If successful, this study could provide evidence to safely expand MRI access to more patients with pacemakers or defibrillators, including those with abandoned leads or needing 3-tesla scans.

What could go wrong

This is an observational registry, not a treatment trial. It only collects data on risks and does not test a new therapy. Results may not change current guidelines if risks are found to be higher than expected.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.